WinHealth and Immedica enter agreement giving Winhealth rights...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
STOCKHOLM and HANGZHOU, China, Dec. 31, 2020 /PRNewswire-AsiaNet/ -- Hongkong WinHealth Pharma Group CO., Ltd and Immedica Pharma AB, today announce that they have entered an agreement under which WinHealth gains the exclusive commercial rights to Ravicti(R) (glycerol phenylbutyrate), in a territory covering the Gr...
Authors: LATEST ASIANET NEWS RELEASES